Safety, Tolerability, and Pharmacokinetics of ICL670, a New Orally Active Iron-Chelating Agent in Patients with Transfusion-Dependent Iron Overload Due to β-Thalassemia von Galanello, Renzo, Piga, Antonio, Alberti, Daniele, Rouan, Marie-Claude, Bigler, Hilde, Séchaud, Romain

Volltext

Pharmacokinetics of the oral direct renin inhibitor aliskiren alone and in combination with irbesartan in renal impairment von Vaidyanathan, Sujata, Bigler, Hilde, Yeh, ChingMing, Bizot, Marie-Noelle, Dieterich, Hans Armin, Howard, Dan, Dole, William P

Volltext

Pharmacokinetics of the oral direct renin inhibitor aliskiren alone and in combination with irbesartan in renal impairment. Commentary von VAIDYANATHAN, Sujata, BIGLER, Hilde, YEH, Chingming, BIZOT, Marie-Noelle, DIETERICH, Hans Armin, HOWARD, Dan, DOLE, William P, SICA, Domenic A

Volltext

Safety, Tolerability, and Pharmacokinetics of ICL670, a New Orally Active Iron-Chelating Agent in Patients with Transfusion-Dependent Iron Overload Due to b-Thalassemia von Galanello, Renzo, Piga, Antonio, Alberti, Daniele, Rouan, Marie-Claude, Bigler, Hilde, Sechaud, Romain

Volltext

Safety, Tolerability, and Pharmacokinetics of ICL670, a New Orally Active Iron-Chelating Agent in Patients with Transfusion-Dependent Iron Overload Due to β-Thalassemia von Galanello, Renzo, Piga, Antonio, Alberti, Daniele, Rouan, Marie-Claude, Bigler, Hilde, Séchaud, Romain

Volltext

The effect of nateglinide on the pharmacokinetics and pharmacodynamics of acenocoumarol von Sunkara, Gangadhar, Bigler, Hilde, Smith, Harold, Prasad, Pratapa, McLeod, James, Ligueros-Saylan, Monica

Volltext